Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
Saved in:
| Title: | Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup. |
|---|---|
| Authors: | Creutzberg CL; Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands. Electronic address: c.l.creutzberg@lumc.nl., Kim JW; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea., Eminowicz G; Department of Clinical Oncology, University College London Hospital, London, UK., Allanson E; Division of Obstetrics and Gynaecology, Medical School, University of Western Australia, Perth, WA, Australia., Eberst L; Department of Medical Oncology, Institut de Cancérologie de Strasbourg, Strasbourg, France., Kim SI; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea., Nout RA; Department of Radiation Oncology, Erasmus Medical Center, Rotterdam, Netherlands., Park JY; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea., Lorusso D; Gynecologic Oncology Unit, Humanitas San Pio X, Milan, Italy; Humanitas University Rozzano, Milan, Italy., Mileshkin L; Department of Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, VIC, Australia., Ottevanger PB; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands., Brand A; Department of Gynaecological Oncology, Westmead Hospital and University of Sydney, Sydney, NSW, Australia., Mezzanzanica D; Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Oza A; Division of Medical Oncology and Hematology, UHN - Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Gebski V; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia., Pothuri B; Perlmutter Cancer Center, NYU Langone Health, New York, NJ, USA; Diversity and Health Equity for Clinical Trials, GOG-Foundation, Philadelphia, PA USA., Batley T; Ko Ngai Tūhoe te iwi, Kaitauwhiro Mātātahi Mokopuna Ora, Te Pūtahitanga o Te Waipounamu, Christchurch, New Zealand., Gordon C; Canadian Cancer Trials Group, London, ON, Canada., Mitra T; Kolkata Gynecological Oncology Trials and Translational Research Group (KolGOTrg), New Town, Kolkata, India., White H; Peaches Womb Cancer Trust, Manchester, UK; Cancer Research Advocates Forum, London, UK., Howitt B; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Matias-Guiu X; Department of Pathology, Hospital U de Bellvitge, University of Barcelona, Barcelona, Spain; Department of Pathology, Hospital U Arnau de Vilanova, University of Lleida, Lleida, Spain., Ray-Coquard I; Centre Leon Berard and Université Claude Bernard, Lyon, France., Gaffney D; Huntsman Cancer Institute, Department of Radiation Oncology, University of Utah, Salt Lake City, UT, USA., Small W Jr; Department of Radiation Oncology, Stritch School of Medicine, Cardinal Bernadin Cancer Center, Loyola University Chicago, Maywood, IL, USA., Miller A; Department of Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Concin N; Department of Gynaecology and Gynaecological Oncology, Medical University of Vienna, Vienna, Austria; Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Innsbruck, Austria., Powell MA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO, USA., Stuart G; Department of Obstetrics and Gynecology, University of British Colombia, Vancouver, BC, Canada., Bookman MA; Kaiser Permanente Northern California, San Francisco, CA, USA. |
| Corporate Authors: | participants of the 2023 Gynecologic Cancer InterGroup Endometrial Cancer Consensus Conference on Clinical Research |
| Source: | The Lancet. Oncology [Lancet Oncol] 2024 Sep; Vol. 25 (9), pp. e420-e431. |
| Publication Type: | Consensus Statement; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
